The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
The Ki-67 protein: From the known and the unknown
Scholzen, T., & Gerdes, J. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200003)182:3<311::aid-jcp1>3.0.co;2-9 · Cited by 4,646
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
G1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,385
Cattoretti, G., Becker, M. H. G., Key, G., Duchrow, M., Schlüuter, C., Galle, J., & Gerdes, J. (1992) · The Journal of Pathology · doi:10.1002/path.1711680404 · Cited by 1,447
Brown, A. S., Brummel‐Smith, K., Burgess, L., D'Agostino, R. B., Goldschmidt, J. W., Halter, J. B., Hazzard, W. R., Jahnigen, D. W., Phelps, C., Raskind, M., et al. (1988) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1988.tb02362.x · Cited by 1,331
Zhou, B. P., Liao, Y., Xia, W., Spohn, B., Lee, M.-H., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/35060032 · Cited by 1,135
Porter, P. L., Malone, K. E., Heagerty, P. J., Alexander, G. M., Gatti, L. A., Firpo, E. J., Daling, J. R., & Roberts, J. M. (1997) · Nature Medicine · doi:10.1038/nm0297-222 · Cited by 901
(2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.13.979 · Cited by 893
Bast, R. C., Ravdin, P., Hayes, D. F., Bates, S., Fritsche, H., Jessup, J. M., Kemeny, N., Locker, G. Y., Mennel, R. G., & Somerfield, M. R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1865 · Cited by 879
Catzavelos, C., Bhattacharya, N., Ung, Y. C., Wilson, J. A., Roncari, L., Sandhu, C., Shaw, P., Yeger, H., Morava-Protzner, I., Kapusta, L., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-227 · Cited by 823
Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers
Hayes, D. F., Bast, R. C., Desch, C. E., Fritsche, H., Kemeny, N. E., Jessup, J. M., Locker, G. Y., Macdonald, J. S., Mennel, R. G., Norton, L., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1456 · Cited by 748
Goldhirsch, A., Wood, W. C., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.576 · Cited by 697
Regulation of the Cdk inhibitor p27 and its deregulation in cancer
Slingerland, J., & Pagano, M. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200004)183:1<10::aid-jcp2>3.0.co;2-i · Cited by 695
Mammalian deoxyribonucleoside kinases
Arnér, E. S. J., & Eriksson, S. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)00015-9 · Cited by 577
Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow Cytometry
Clark, G. M., Dressler, L. G., Owens, M. A., Pounds, G., Oldaker, T., & McGuire, W. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903093201003 · Cited by 558
Cyclin E and Survival in Patients with Breast Cancer
Keyomarsi, K., Tucker, S. L., Buchholz, T. A., Callister, M., Ding, Y., Hortobagyi, G. N., Bedrosian, I., Knickerbocker, C., Toyofuku, W., Lowe, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021153 · Cited by 557
Ki67 protein: the immaculate deception?
Brown, D. C., & Gatter, K. C. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.01343.x · Cited by 509
Järvinen, T. A. H., Tanner, M., Rantanen, V., Bärlund, M., Borg, Å., Grénman, S., & Isola, J. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64952-8 · Cited by 387
Prognostic value of proliferation in invasive breast cancer: a review: Table 1
van Diest, P. J., van der Wall, E., & Baak, J. P. A. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.010777 · Cited by 385
Foulkes, W. D., Brunet, J.-S., Stefansson, I. M., Straume, O., Chappuis, P. O., Bégin, L. R., Hamel, N., Goffin, J. R., Wong, N., Trudel, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2970 · Cited by 363
Fredersdorf, S., Burns, J., Milne, A. M., Packham, G., Fallis, L., Gillett, C. E., Royds, J. A., Peston, D., Hall, P. A., Hanby, A. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6380 · Cited by 357
Indicators of Prognosis in Node-Negative Breast Cancer
Sigurdsson, H., Baldetorp, B., Borg, Å., Dalberg, M., Fernö, M., Killander, D., & Olsson, H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004123221505 · Cited by 337
Cyclin D1 and prognosis in human breast cancer
Gillett, C., Smith, P., Gregory, W., Richards, M., Millis, R., Peters, G., & Barnes, D. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960422)69:2<92::aid-ijc4>3.0.co;2-q · Cited by 327
P27kip1 Down-Regulation Is Associated with Trastuzumab Resistance in Breast Cancer Cells
Nahta, R., Takahashi, T., Ueno, N. T., Hung, M.-C., & Esteva, F. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3900 · Cited by 298
Leo, A. D., Gancberg, D., Larsimont, D., Tanner, M., Järvinen, T. A. H., Rouas, G., Dolci, S., Leroy, J.-Y., Paesmans, M., Isola, J. J., et al. (2002) · PubMed · Cited by 267
Self-citationSutherland, R. L., & Musgrove, E. A. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000023591.45568.77 · Cited by 258
Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells.
Hsiang, Y. H., Wu, H. Y., & Liu, L. F. (1988) · PubMed · Cited by 247
Kenny, F. S., Hui, R., Musgrove, E. A., Gee, J. M. W., Blamey, R. W., Nicholson, R. I., Sutherland, R. L., & Robertson, J. F. R. (1999) · PubMed · Cited by 245
Barnes, D. M., & Gillett, C. E. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006103831990 · Cited by 243
Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.
van Diest, P. J., Michalides, R. J. A. M., Jannink, L., van der Valk, P., Peterse, H. L., de Jong, J. S., Meijer, C. J. L. M., & Baak, J. P. A. (1997) · Europe PMC (PubMed Central) · Cited by 207
Möröy, T., & Geisen, C. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.12.005 · Cited by 202
Coon, J. S., Marcus, E., Gupta-Burt, S., SEELIG, S. A., Jacobson, K., Chen, S., RENTA, V., Fronda, G., & Preisler, H. D. (2002) · PubMed · Cited by 193
Nielsen, N., Arnerlöv, C., Emdin, S. O., & Landberg, G. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.451 · Cited by 192
Consensus review of the clinical utility of dna cytometry in carcinoma of the breast
Hedley, D. W., Clark, G. M., Cornelisse, C. J., Killander, D., Kute, T., & Merkel, D. (1993) · Cytometry · doi:10.1002/cyto.990140505 · Cited by 192
Trihia, H., Murray, S., Price, K., Gelber, R. D., Golouh, R., Goldhirsch, A., Coates, A. S., Collins, J., Castiglione‐Gertsch, M., & Gusterson, B. A. (2003) · Cancer · doi:10.1002/cncr.11188 · Cited by 189
Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer.
Järvinen, T. A. H., Tanner, M., Barlund, M. T., Borg, Å., & Isola, J. J. (1999) · PubMed · Cited by 188
Keshgegian, A. A., & Cnaan, A. (1995) · American Journal of Clinical Pathology · doi:10.1093/ajcp/104.1.42 · Cited by 184
Michalides, R., Hageman, P., van Tinteren, H., Houben, L., Wientjens, E., Klompmaker, R., & Peterse, J. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.128 · Cited by 184
The relationship between prognostic and predictive factors in the management of breast cancer
Henderson, I. C., & Patek, A. J. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006141703224 · Cited by 184
Pinder, S., Wencyk, P., Sibbering, D., Bell, J., Elston, C., Nicholson, R., Robertson, J., Blamey, R., & Ellis, I. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.30 · Cited by 179
Cyclin E2, a Novel G1 Cyclin That Binds Cdk2 and Is Aberrantly Expressed in Human Cancers
M. Gudas, J., Payton, M., Thukral, S., Chen, E., Bass, M., Robinson, M. O., & Coats, S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.612 · Cited by 174
Relationship between labeling indices of KI-67 and brdurd in human malignant tumors
Sasaki, K., Matsumura, K., Tsuji, T., Shinozaki, F., & Takahashi, M. (1988) · Cancer · Cited by 172
Stendahl, M., Kronblad, Å., Rydén, L., Emdin, S., Bengtsson, N. O., & Landberg, G. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601831 · Cited by 169
DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients
Wenger, C. R., Beardslee, S., Owens, M. A., Pounds, G., Oldaker, T., Vendely, P., Pandian, M. R., Harrington, D., Clark, G. M., & McGuire, W. L. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00666351 · Cited by 169
Akli, S., Zheng, P., Multani, A. S., Wingate, H. F., Pathak, S., Zhang, N., Tucker, S. L., Chang, S. S., & Keyomarsi, K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3672 · Cited by 152
Ye, D., Mendelsohn, J. M., & Fan, Z. (1999) · Oncogene · doi:10.1038/sj.onc.1202319 · Cited by 151
Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle
Lauper, N., Beck, A., Cariou, S., Richman, L., Hofmann, K., Reith, W., Slingerland, J. M., & Amati, B. B. (1998) · Oncogene · doi:10.1038/sj.onc.1202477 · Cited by 150
Caffo, O., Doglioni, C., Veronese, S. M., Bonzanini, M., Marchetti, A., Buttitta, F., Fina, P., Leek, R., Morelli, L., Palma, P., et al. (1996) · PubMed · Cited by 142
Thor, A. D., Liu, S., Moore, D. H., & Edgerton, S. M. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.470 · Cited by 137
Chappuis, P. O., Kapusta, L. R., Bégin, L. R., Wong, N., Brunet, J., Narod, S. A., Slingerland, J. M., & Foulkes, W. D. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.24.4045 · Cited by 134
p27 Deregulation in Breast Cancer: Prognostic Significance and Implications for Therapy
Alkarain, A., Jordan, R. C., & Slingerland, J. M. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000023589.00994.5e · Cited by 130
Giles, K. M., Daly, J. M., Beveridge, D. J., Thomson, A. M., Voon, D. C., Furneaux, H. M., Jazayeri, J. A., & Leedman, P. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208439200 · Cited by 124
Park, K., Kim, J., Lim, S., & Han, S. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00745-1 · Cited by 113
Prognostic value of Ki-67 compared to S-phase fraction in axillary node-negative breast cancer.
Brown, R. W., Allred, C., Clark, G. M., Osborne, C. K., & Hilsenbeck, S. G. (1996) · PubMed · Cited by 109
Lodén, M., Stighall, M., Nielsen, N. H., Roos, G., Emdin, S. O., Östlund, H., & Landberg, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205578 · Cited by 107
MIB-1 labelling index is an independent prognostic marker in primary breast cancer
Jansen, R. L. H., Hupperets, P. S. G. J., Arends, J. W., Joosten-Achjanie, S., Volovics, A., Schouten, H. C., & Hillen, H. F. P. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.515 · Cited by 106
Zariwala, M. A., Liu, J., & Xiong, Y. (1998) · Oncogene · doi:10.1038/sj.onc.1202505 · Cited by 106
Consensus Report of the Task Force on Standardisation of DNA Flow Cytometry in Clinical Pathology
Ormerod, M. G., Tribukait, B., & Giaretti, W. (1998) · Analytical Cellular Pathology · doi:10.1155/1998/842306 · Cited by 101
Umekita, Y., Ohi, Y., Sagara, Y., & Yoshida, H. (2002) · International Journal of Cancer · doi:10.1002/ijc.10151 · Cited by 98
Pellikainen, M. J., Pekola, T. T., Ropponen, K. M., Kataja, V. V., Kellokoski, J. K., Eskelinen, M. J., & Kosma, V.-M. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.3.214 · Cited by 93
Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer
Span, P. N., Tjan‐Heijnen, V. C. G., Manders, P., Beex, L. V. A. M., & Sweep, F. C. G. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206818 · Cited by 93
Seshadri, R., Leong, A. S. ‐., McCaul, K. A., Firgaira, F. A., Setlur, V., & Horsfall, D. J. (1996) · International Journal of Cancer · Cited by 90
Clahsen, P. C., de Velde, C. J. H. V., Duval, C., Pallud, C., Mandard, A. M., Delobelle-Deroïde, A., van den Broek, L., & van de Vijver, M. J. (1999) · European Journal of Surgical Oncology · doi:10.1053/ejso.1999.0657 · Cited by 90
Broët, P., Romain, S., Daver, A., Ricolleau, G., Quillien, V., Rallet, A., Asselain, B. J. R., Martin, P., & Spyratos, F. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.11.2778 · Cited by 88
Expression of cyclins E, A, and B, and prognosis in lymph node‐negative breast cancer
Kühling, H., Alm, P., Olsson, H. L., Fernö, M., Baldetorp, B., Parwaresch, R. M., & Rudolph, P. (2003) · The Journal of Pathology · doi:10.1002/path.1322 · Cited by 81
Gasparini, G., Boracchi, P., Verderio, P., & Bevilacqua, P. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570610 · Cited by 81
Rudolph, P., Kühling, H., Alm, P., Fernö, M., Baldetorp, B., Olsson, H. L., & Parwaresch, R. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11132 · Cited by 77
Hwang, T. S., Han, H. S., Hong, Y. C., Lee, H. J., & Paik, N. S. (2003) · Pathology International · doi:10.1046/j.1440-1827.2003.01441.x · Cited by 77
Malmström, P., Bendahl, P.-O., Boiesen, P., Brünner, N., Idvall, I., & Fernö, M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.7.2010 · Cited by 75
Geisen, C., & Möröy, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205919200 · Cited by 73
Prognostic role of p27Kip1 and apoptosis in human breast cancer
Wu, J., Shen, Z.-Z., Lu, J.-S., Jiang, M., Qx, H., Fontana, J. A., Barsky, S. H., & Shao, Z.-M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690250 · Cited by 72
Assersohn, L., Salter, J., Powles, T. J., A’Hern, R., Makris, A., Gregory, R. K., Chang, J. C., & Dowsett, M. (2003) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000003968.45511.3f · Cited by 69
Domagała, W., Markiewski, M. M., Harezga, B., Dukowicz, A., & Osborn, M. (1996) · PubMed · Cited by 68
Donnellan, R. B., Kleinschmidt, I., & Chetty, R. (2001) · Human Pathology · doi:10.1053/hupa.2001.21141 · Cited by 67
Gaglia, P., Bernardi, A., Venesio, T., Caldarola, B., Lauro, D., Cappa, A. P. M., Calderini, P., & Liscia, D. S. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90284-m · Cited by 66
Pelosio, P., Barbareschi, M., Bonoldi, E., Marchetti, A., Verderio, P., Caffo, O., Bevilacqua, P., Boracchi, P., Buttitta, F., Barbazza, R., et al. (1996) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a010718 · Cited by 66
Gillett, C., Smith, P., Peters, G. G., Lü, X., & Barnes, D. M. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199901)187:2<200::aid-path228>3.0.co;2-m · Cited by 64
Role of proliferation in HER2 status predicted response to doxorubicin
Campiglio, M., Somenzi, G., Olgiati, C., Beretta, G. L., Balsari, A., Zaffaroni, N., Valagussa, P., & Ménard, S. (2003) · International Journal of Cancer · doi:10.1002/ijc.11113 · Cited by 57
Cyclin E2, the cycle continues
Payton, M. N., & Coats, S. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00137-6 · Cited by 57
Pinto, A. E., André, S., & Soares, J. (1999) · Journal of Clinical Pathology · doi:10.1136/jcp.52.8.604 · Cited by 55
Durbecq, V., Desmed, C., Paesmans, M., Cardoso, F., Leo, A. D., Mano, M. S., Rouas, G., Leroy, J.-Y., Sotiriou, C. P., Piccart, M. J., et al. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.5.1473 · Cited by 53
Self-citationPohl, G., Rudas, M., Dietze, O., Lax, S., Markis, E., Pirker, R., Zielinski, C. C., Hausmaninger, H., Kubista, E., Samonigg, H., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.021 · Cited by 53
Reed, W., Flørenes, V. A., Holm, R., Hannisdal, E., & Nesland, J. M. (1999) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050408 · Cited by 51
Dupont, J., Karas, M., & LeRoith, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302355200 · Cited by 50
Correlation of p27 protein expression with HER‐2/neu expression in breast cancer
Newman, L. A., Xia, W., Yang, H.-Y., Sahin, A., Bondy, M. L., Lukmanji, F., Hung, M., & Lee, M. (2001) · Molecular Carcinogenesis · doi:10.1002/mc.1025 · Cited by 49
Domagała, W., Welcker, M., Chosia, M., Karbowniczek, M., Harezga, B., Bártková, J., Bártek, J., & Osborn, M. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280100410 · Cited by 47
The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67
Goodson, W. H., Moore, D. H., Ljung, B., Chew, K., Mayall, B. H., Smith, H. S., & Waldman, F. M. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006344010050 · Cited by 47
p21waf correlates with DNA replication but not with prognosis in invasive breast cancer
Göhring, U.-J., Bersch, A., Becker, M., Neuhaus, W., & Schöndorf, T. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.11.866 · Cited by 46
Bagwell, C. B., Gm, C., Spyratos, F., Chassevent, A., Bendahl, P.-O., Stål, O., Killander, D., Jourdan, M., Romain, S., Hunsberger, B. C., et al. (2001) · Cytometry · doi:10.1002/cyto.1097 · Cited by 45
Yang, W., Klos, K. S., Zhou, X., Yao, J., Yang, Y., Smith, T. L., Shi, D., & Yu, D. (2003) · Cancer · doi:10.1002/cncr.11625 · Cited by 42
p27 Expression Correlates with Short-Term, but not with Long-Term Prognosis in Breast Cancer
Leivonen, M., Nordling, S., Lundin, J. E., von Boguslawski, K., & Haglund, C. H. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1010623326118 · Cited by 40
Ceccarelli, C., Santini, D., Chieco, P., Lanciotti, C., Taffurelli, M., Paladini, G., & MARRANO, D. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010320)95:2<128::aid-ijc1022>3.0.co;2-d · Cited by 39
Estrogen-replacement therapy after breast cancer risks versus benefits
Marchant, D. J. (1993) · Cancer · doi:10.1002/1097-0142(19930315)71:6+<2157::aid-cncr2820711606>3.0.co;2-o · Cited by 37
Skildum, A. J., Mukherjee, S., & Conrad, S. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109179200 · Cited by 37
Nohara, T., Toshio, R. Y. O., IWAMOTO, S., Gon, G., & Tanigawa, N. (2000) · Oncology · doi:10.1159/000055303 · Cited by 37
WAF1/CIP1 protein expression in human breast tumors
Diab, S., Yu, Y.-Y., Hilsenbeck, S. G., Allred, D. C., & Elledge, R. M. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005752829260 · Cited by 36
p21WAF1/CIP1 Expression in breast cancers: associations with p53 and outcome
Thor, A. D., Liu, S., Moore, D. H., Shi, Q., & Edgerton, S. M. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006455526894 · Cited by 35
Witzig, T. E., Gonchoroff, N. J., Therneau, T. M., Gilbertson, D. T., Wold, L. E., Grant, C. S., Grande, J. P., Katzmann, J. A., Ahmann, D. L., & Ingle, J. N. (1991) · Cancer · doi:10.1002/1097-0142(19911015)68:8<1781::aid-cncr2820680822>3.0.co;2-0 · Cited by 30
Mathoulin-Portier, M.-P., Viens, P., Cowen, D. M., Bertucci, F., Houvenaeghel, G. F., Geneix, J., Puig, B. C.-V. I., Bardou, V. J., & Jacquemier, J. D. (2000) · Oncology Reports · doi:10.3892/or.7.3.675 · Cited by 12
Cited by
Györffy, B., Lanczky, A., Eklund, A. C., Denkert, C., Budczies, J., Li, Q., & Szallasi, Z. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0674-9 · Cited by 4,169
Harris, L., Fritsche, H., Mennel, R., Norton, L., Ravdin, P., Taube, S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,217
Ki67 in breast cancer: prognostic and predictive potential
Yerushalmi, R., Woods, R., Ravdin, P. M., Hayes, M. M., & Gelmon, K. A. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70262-1 · Cited by 1,207
Sturgeon, C. M., Duffy, M. J., Stenman, U.-H., Lilja, H., Brünner, N., Chan, D. W., Babaian, R., Bast, R. C., Dowell, B., Esteva, F. J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105601 · Cited by 1,129
de Azambuja, E., Cardoso, F., de Castro, G., Colozza, M., Mano, M. S., Durbecq, V, Sotiriou, C., Larsimont, D., Piccart-Gebhart, M. J., & Paesmans, M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603756 · Cited by 959
Self-citation
Metadata
- Authors
- Colozza, M., Azambuja, E., Cardoso, F., Sotiriou, C., Larsimont, D., & Piccart, M. J.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2005-11
- Volume
- 16
- Issue
- 11
- Pages
- 1723-1739
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2119805291
- Cited by
- 307
- References
- 101
- FWCI
- 5.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.